A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant
To determine whether zidovudine (AZT) in conjunction with bone marrow transplantation prevents the reinfection of donor hematopoietic/lymphoid cells in patients with positive HTLV III antibody and large cell/diffuse histiocytic lymphoma. Patients who are candidates will be evaluated for HTLV III activity and drug levels.
|Study Design:||Primary Purpose: Treatment|
|Official Title:||A Pilot Study To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients Receiving a Bone Marrow Transplant|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00002284
|United States, Maryland|
|Johns Hopkins Hemapheresis Treatment Ctr|
|Baltimore, Maryland, United States, 21205|